|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,327.00 JPY | +1.68% |
|
+5.68% | +11.18% |
| 08-06 | Japan Earnings Wrap: Kao, Astellas Pharma Rise; Taiyo Yuden Declines | MT |
| 08-05 | Merck's Keytruda Gets Canadian Approval to Treat Muscle-Invasive Bladder Cancer | MT |
| Market Cap | 4,172B 26.46B 22.89B 21.37B 19.61B 36.87B 2,518B 37.46B 251B 98.42B 1,262B 99.35B 97.18B | P/E 2027 * |
11.6x | P/E 2028 * | 12.2x |
|---|---|---|---|---|---|
| Enterprise Value | 4,183B 26.53B 22.95B 21.43B 19.66B 36.97B 2,525B 37.56B 251B 98.68B 1,265B 99.62B 97.44B | EV / Sales 2027 * |
1.83x | EV / Sales 2028 * | 1.79x |
| Free-Float |
98.88% | Yield 2027 * |
3.45% | Yield 2028 * | 3.56% |
Last Transcript: Astellas Pharma Inc.
| 1 day | +1.68% | ||
| 1 week | +5.68% | ||
| Current month | +5.68% | ||
| 1 month | +7.01% | ||
| 3 months | +1.09% | ||
| 6 months | -4.67% | ||
| Current year | +11.18% |
| 1 week | 2,125 |  | 2,336 |
| 1 month | 2,109 | | 2,336 |
| Current year | 2,041 | | 2,717 |
| 1 year | 1,557.5 | | 2,717 |
| 3 years | 1,243.5 | | 2,717 |
| 5 years | 1,243.5 | | 2,717 |
| 10 years | 1,243.5 | | 2,717 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 63 | 09/02/2023 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 54 | 31/10/2023 |
Tatjana Dragovic
CMP | Compliance Officer | - | 31/03/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenji Yasukawa
CHM | Chairman | 66 | 09/02/2023 |
Naoki Okamura
BRD | Director/Board Member | 63 | 31/05/2019 |
| Director/Board Member | 58 | 31/05/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.68% | +5.68% | +45.03% | +6.21% | 26.46B | |
| -0.52% | +3.21% | +85.02% | +161.12% | 1,057B | |
| +0.88% | +1.13% | +51.13% | +49.76% | 625B | |
| +0.89% | -1.95% | +23.73% | +63.67% | 435B | |
| +0.71% | +3.87% | +47.45% | +38.68% | 363B | |
| +0.64% | -0.49% | +35.39% | +40.21% | 296B | |
| +0.39% | -5.83% | +8.64% | +9.28% | 249B | |
| +1.51% | +6.69% | +44.34% | +62.47% | 222B | |
| +3.92% | -0.46% | -1.21% | -44.09% | 209B | |
| +1.80% | +2.30% | +20.79% | +65.13% | 165B | |
| Average | +1.35% | +1.35% | +36.03% | +45.24% | 364.72B | |
| Weighted average by Cap. | +1.13% | +1.25% | +48.31% | +74.83% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2,288B 14.51B 12.55B 11.72B 10.75B 20.23B 1,381B 20.55B 138B 53.98B 692B 54.49B 53.3B | 2,101B 13.32B 11.52B 10.76B 9.87B 18.57B 1,268B 18.86B 126B 49.56B 636B 50.03B 48.93B |
| Net income | 358B 2.27B 1.97B 1.84B 1.68B 3.17B 216B 3.22B 21.54B 8.46B 108B 8.54B 8.35B | 341B 2.16B 1.87B 1.74B 1.6B 3.01B 206B 3.06B 20.47B 8.03B 103B 8.11B 7.93B |
| Net Debt | 11.12B 70.53M 61.01M 56.97M 52.27M 98.31M 6.71B 99.87M 668M 262M 3.36B 265M 259M | -418B -2.65B -2.29B -2.14B -1.96B -3.69B -252B -3.75B -25.1B -9.85B -126B -9.95B -9.73B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/08/26 | JP¥2,327.00 | +1.68% | 8,001,800 |
| 06/08/26 | JP¥2,288.50 | +6.00% | 10,352,900 |
| 05/08/26 | JP¥2,159.00 | -0.44% | 5,388,800 |
| 04/08/26 | JP¥2,168.50 | -0.34% | 6,719,900 |
| 03/08/26 | JP¥2,176.00 | -1.18% | 7,373,300 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
Select your edition
All financial news and data tailored to specific country editions
